logologo
Search anything
arrow

Stock Summary and Key Metrics













discovery-starDiscovery themes featuring this stock




Investment Checklist


























Price
PE Ratio
Price

Overview

Detailed Summary
  • Key insightKey insight

    Smruthi Organics Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) focusing on anti-diabetic, anti-hypertension, and anti-infectives categories. They cater to a global clientele across Asia, Americas, and Africa.

  • Key insightKey insight

    The company operates two manufacturing facilities in Solapur, India, and has progressively expanded its product offerings since its incorporation in 1989.

  • Key insightKey insight

    In 2021-22, the Finished Dosage Formulations (FDF) division was fully operational, showcasing industrial advancement and scaling the company's capacity to deliver pharmaceutical products comprehensively.

  • Key insightKey insight

    Smruthi Organics has expanded its brand portfolio with the launch of 'ENERLIN' and 'SOLSITA', highlighting their commitment to innovation and market diversification.

Sector

Pharmaceuticals & Biotechnology

Industry

Pharmaceuticals

Market Cap

140 Cr

Volatility

Low Risk

P/E Ratio

40.7

Industry P/E

33.7

PEG Ratio

7.5

P/B Ratio

1.9

52W High

164.00

52W Low

95.00

Financial Ratios

Sales CAGR

1Y
-1.28%
3Y
-1.88%
5Y
-0.79%
10Y
5.54%

Profit CAGR

1Y
-0.84%
3Y
-29.99%
5Y
-15.86%
10Y
19.38%

ROE

TTM
4.66%
3Y
5.39%
5Y
11.50%
10Y
10.47%

ROCE

TTM
7.75%
3Y
8.14%
5Y
15.95%
10Y
16.60%

Forecasts

No ConstituentsNo Constituents

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Standalone Quarterly Results (in ₹ Crores)

Total Figures
QoQ Changes
Total Figures
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales23402729313819322229
Expenses25362727273319271825
Operating Profit-1.184.090.442.894.164.670.235.014.003.79
OPM %-5.0310.311.619.8313.3112.261.2115.8517.9513.03
Other Income0.000.060.000.010.000.080.090.01-0.440.01
Interest0.320.370.410.440.510.520.460.660.250.31
Depreciation1.451.591.291.331.371.501.411.511.671.75
Profit Before Tax-2.952.19-1.251.132.292.73-1.552.851.631.74
Tax %22.3730.5926.4031.8635.3718.3229.6827.7214.1138.51
Net Profit-2.291.52-0.920.781.482.23-1.102.061.401.07
EPS in Rs-2.001.33-0.810.681.291.95-0.961.801.220.93

Standalone Profit Loss (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales8598137131127133141128126118
Expenses699412111698115131116114106
Operating Profit163.86171529189.78121212
OPM %18.543.9412.0711.6222.5613.826.939.379.6710.15
Other Income0.980.210.884.420.560.580.110.080.09NaN
Interest4.374.093.583.181.090.980.821.411.871.93
Depreciation3.974.074.144.393.954.264.575.655.505.61
Profit Before Tax2.59-4.689.761224144.494.974.904.60
Tax %38.8931.4029.6730.1428.8824.628.0727.7627.2926.30
Net Profit1.58-3.216.868.4517104.133.593.563.39
EPS in Rs4.75-3.055.927.3811.979.063.403.143.112.99
Dividend Payout %0.000.0011.1213.5520.0733.0851.6847.7748.23

Standalone Balance Sheet (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital3.823.823.823.823.821111111111
Reserves27282533394956575860
Borrowings31272928169.902.825.701217
Other Liabilities41262737302118323723
Total Liabilities1038585101889288106118112
Fixed Assets32303030323133374045
CWIP1.091.300.531.690.190.840.801.991.432.55
Investments0.340.050.050.050.050.050.050.120.130.16
Other Assets69545469566053667764
Total Assets1038585101889288106118112

Standalone Cash Flows (in ₹ Crores)

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity149.175.141221232.17124.409.98
Cash from Investing Activity0.16-0.48-3.21-4.50-4.52-3.407.15-10-7.16-11
Cash from Financing Activity-14-8.68-1.77-5.15-17-6.86-12-1.522.661.40
Net Cash Flow-0.060.020.162.43-0.5813-2.790.34-0.11-0.04

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium